EXOR N.V.
VC Fund
Amsterdam, The Netherlands
EXOR N.V. is a VC fund in Amsterdam focused on Software and Health Care. EXOR is a holding company based in the Netherlands that the Agnelli family controls. The company has a diverse portfolio of investments in various industries, including automotive, real estate, and finance. The company is known for taking a long-term approach to its assets and has a reputation for being a patient and value-oriented investor. Thecompany's primary focus is on creating long-term value for its shareholders by actively managing and growing its portfolio of investments.EXOR's core mission is to cultivate exceptional enterprises, simultaneously nurturing opportunities for its talented workforce to flourish, make meaningful societal contributions, and yield outstanding returns for its valued investors.
- Total investments:
- 148
- Last investment:
- Lead investor:
- 24%
Last updated:
For AI agents: llms.txt
Industries EXOR N.V. invests in
Stages EXOR N.V. invests in
Countries EXOR N.V. invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $1.8M–$18M
- Pre-Seed
- $320k–$5.1M
- Series A
- $9.5M–$60M
Investment Focus
Industry
- Software 23 (16%)
- Health Care 18 (12%)
- Artificial Intelligence 17 (11%)
- FinTech 13 (9%)
- Information Technology 12 (8%)
Stage
- Seed 30 (20%)
- Series A 23 (16%)
- Pre-Seed 20 (14%)
- Series B 13 (9%)
- Venture - Series Unknown 13 (9%)
Country
- United States 34 (23%)
- Italy 23 (16%)
- France 13 (9%)
- United Kingdom 13 (9%)
- Israel 4 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Alim Shaikh
Investor
|
Investor | Total investments: 2 | Find email | |
Arnaud Sahuguet
Venture Partner at EXOR Seeds
|
Venture Partner at EXOR Seeds | Total investments: 0 | Find email | |
Benoît RIBADEAU-DUMAS
Partner
|
Partner | Total investments: 0 | Find email | |
Enrico Vellano
CFO
|
CFO | Total investments: 0 | Find email | |
John Elkann
CEO
|
CEO | Total investments: 9 | Find email | |
| See all 8 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Q.ai
|
Q.ai provides systems designed to support high data throughput, multilingual interaction, privacy controls, and accessibility features within communication workflows. Its technology is used to enhance real-time and asynchronous interactions between users who operate across different languages and regions. Q.ai’s platform is designed to integrateinto existing applications and services, supporting organizations that require consistent communication standards across distributed teams and audiences. | Private Equity / Jan 29, 2026 | |
RobCo
|
RobCo is a company that develops modular industrial robotics systems combined with AI-driven software to automate manual and repetitive tasks in manufacturing environments. It provides a platform that includes configurable robotic hardware, no-code programming tools, AI-powered vision systems, and digital simulation to plan, test, and deployautomation workflows across applications like machine loading, palletizing, and materials handling. The company’s solutions are designed to be flexible and scalable so manufacturers can adapt robot configurations as production requirements evolve. RobCo also offers tools for remote management, predictive maintenance, and integration with existing equipment to support continuous operation. Its products aim to simplify the adoption of robotics by reducing the need for specialized programming and enabling simulation-based validation before physical deployment. | $100M / Series C / Jan 29, 2026 | |
Lyte AI
|
Lyte.ai develops end-to-end perception platforms for Physical AI and robotics, integrating custom silicon, sensors, compute, and software to enable safe navigation in complex environments.The company offers LyteVision, a unified 4D vision system combining RGB imaging, motion awareness, and depth sensing for robots, drones, and autonomous vehicles.This "visual brain" draws from founders' Face ID expertise, powering applications in robotic arms, quadrupeds, robotaxis, and humanoids. | $107M / Venture - Series Unknown / Jan 05, 2026 | |
Upway
|
Upway offers an online platform focused on refurbished electric bicycles, providing consumers with access to inspected, repaired, and certified e-bikes from a variety of categories, including city, cargo, mountain, and folding models. The company acquires used or excess bikes from individuals, retailers, and fleets, performs comprehensivemechanical and electrical reconditioning, and then resells the bikes with a one-year warranty and delivery service. Upway also offers a trade-in option for owners looking to sell their e-bike, and supplies accessories like locks, lights, and bags to complement the purchase. The business emphasizes sustainable mobility by extending the life of existing e-bikes and delivering them at a lower cost than typical new bike retail. | $60M / Series C / Nov 06, 2025 | |
Stardust
|
Stardust a research company dedicated to investigating the responsible use of Stratospheric Aerosol Injection technology. | $60M / Venture - Series Unknown / Oct 24, 2025 | |
Plino
|
Plino is the SMEs FP&A co-pilot, integrating your company data and making it faster and easier to analyse them, empowering entrepreneurs in taking successful informed decisions. On one side it collects, organizes and analyses data from different company’s data sources such as invoices, bank accounts, MES, ERP, WMS, industry 4.0 data, andcompany documents (contracts, technical data sheets). On the other, it provides a user-friendly chat where the user (either the entrepreneur, the CFO, or the accountant) can type questions and receive fast, precise and insightful answers on the company’s revenues, costs, clients, products, and production process. Its mission is to empower SME’s managers to take better informed strategic decisions to lead the company to scale toward success by overcoming market uncertainty. | $764.6K / Pre-Seed / Sep 15, 2025 | |
PhaseV
|
PhaseV is creating tools and cutting-edge statistical approaches to transform trial design, execution, and analysis. PhaseV recognizes hidden signals in clinical data and extracts actionable insights to help determine the best next moves. The company's technology provides optimal adaptive clinical trial design and closed-loop execution,enhancing efficiency and success rates. PhaseV is developing clinical trial paradigm shifts in order to provide novel therapies to more people in a more precise and efficient manner. | $50M / Series A / May 13, 2025 | |
HypeSound
|
Hypesound is revolutionizing the fermentation industry with its innovative sound wave technology. The company is utilizing sonic technology to boost the productivity of algae, yeast, and bacteria, paving the way for sustainable bioproduction and the next industrial revolution. | $1.3M / Pre-Seed / Mar 24, 2025 | |
Philips
|
Koninklijke Philips is a technology company that provides healthcare, consumer lifestyle, and lighting products, solutions, and services. The company offers professionals with healthcare, lighting, and oral healthcare products, professional dictation, and display solutions, and innovation services. It offers consumers electronic products related tosound and vision, personal care, mother and child care, housewares, lighting, PCs and phones, and more. | Post-IPO Equity / Mar 19, 2025 | |
Byzantine Finance
|
Byzantine is the gateway infrastructure for restaking. We enable anyone to build customizable restaking vaults that give them full control over their risks and rewards. The Byzantine protocol is designed to make risk management of restaking strategies permissionless and flexible allowing for a more competitive, risk-optimised yield. | $3M / Pre-Seed / Feb 25, 2025 | |
| See all 148 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does EXOR N.V. invest in?
EXOR N.V. invests primarily in Software, Health Care and Artificial Intelligence startups, most often at Seed and Series A stage. Most of the 148 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is EXOR N.V.'s check size?
EXOR N.V. typically joins rounds of $1.8M–$18M at Seed, $320k–$5.1M at Pre-Seed and $9.5M–$60M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds EXOR N.V. participates in.
How do I contact EXOR N.V.?
Public channels for EXOR N.V. include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at EXOR N.V.?
The team at EXOR N.V. includes Alim Shaikh (Investor), Arnaud Sahuguet (Venture Partner at EXOR Seeds) and Benoît RIBADEAU-DUMAS (Partner), among 8 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
